Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein Inc. (symbol: HSIC) is the world's largest provider of healthcare products and services to office-based dental, animal health, and medical practitioners. As a Fortune 500® company and a member of the S&P 500® and NASDAQ 100® indexes, Henry Schein employs more than 18,000 team members and serves over one million customers globally. The company's offerings extend to dental laboratories, government and institutional healthcare clinics, and other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, offering a comprehensive selection of more than 100,000 branded products and private-label products, as well as over 150,000 additional products available as special-order items.
The company is organized into two main segments: Healthcare Distribution and Technology & Value-Added Services. The Healthcare Distribution segment focuses on distributing consumable products, small equipment, and laboratory products. The Technology & Value-Added Services segment provides innovative software solutions and other technology services designed to help healthcare practitioners run their practices more efficiently and deliver high-quality care.
In recent years, Henry Schein has achieved significant milestones, including expanding its product range and forming strategic partnerships to enhance its service offerings. The company continues to innovate with exclusive technology solutions aimed at improving practice management and patient care.
Henry Schein, Inc. (HSIC) has acquired a majority stake in Prism Medical Products, LLC, a provider of specialty home medical supplies, particularly in advanced wound care. This acquisition expands Henry Schein Medical’s reach into the multibillion-dollar home medical equipment market. Prism, founded in 2006, reported approximately $52 million in net revenue for the year ending September 30, 2020. The acquisition is expected to be neutral to earnings in 2021 and accretive thereafter. PRISM will operate as a subsidiary managed by its founder Chris Cartwright.
Henry Schein (Nasdaq: HSIC) and Casa Schmidt have established a joint venture aimed at enhancing dental practice efficiency in Spain and Portugal. Announced on March 10, 2020, and approved on June 30, 2020, the venture will leverage Henry Schein's extensive solutions portfolio and Casa Schmidt's distribution network, including Schmidt Dental Solutions, Servimed, and specialized implant products. Henry Schein will hold majority ownership, with senior management from both companies. This collaboration is expected to deliver comprehensive, high-quality services to dental professionals in the Iberian market.
Henry Schein, the world’s largest provider of health care solutions for dental and medical practitioners, will present virtually at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 7:30 a.m. ET. Investors can access the live webcast via Henry Schein's website, with a replay available afterward. The company has over 19,000 team members and serves more than 1 million customers globally, delivering over 300 solutions to enhance operational success in healthcare.
Henry Schein Medical has announced the availability of Ansell Healthcare's AlphaTec® Model 214 gowns in North America. These non-surgical isolation gowns are made from DuPont™ Tyvek® 1222A fabric, providing superior chemical protection for front-line healthcare workers amid COVID-19. The partnership aims to enhance the accessibility of personal protective equipment (PPE) for healthcare institutions. The gowns feature advanced barrier protection and are available in two sizes, helping fulfill the increasing demand for reliable PPE in the healthcare sector.
Henry Schein Medical has partnered with Yosi Health to enhance patient experiences and streamline administrative processes through Yosi Intake, a digital patient scheduling and registration solution. This collaboration aims to create contactless waiting room experiences, increasing efficiency for healthcare practices. The partnership expands Henry Schein's SolutionsHub, providing a comprehensive suite of customizable solutions that meet the needs of various medical practices and facilities. This partnership is positioned to modernize patient visits while reducing costs and improving overall care quality.
Henry Schein, Inc. (Nasdaq: HSIC) commemorates its 25th anniversary as a public company by opening the Nasdaq Stock Market. The company raised $72.8 million during its IPO in 1995, and has since expanded significantly, achieving $10 billion in sales from continuing operations by 2019. With a market capitalization around $10 billion and over 19,000 employees serving more than one million customers globally, Henry Schein ranks on FORTUNE® magazine’s lists of the World’s Most Admired Companies and the World’s Most Ethical Companies.
Henry Schein (Nasdaq: HSIC) announces participation in the virtual Greater New York Dental Meeting (GNYDM) from November 27 to December 2. The company's virtual booths will showcase 3D imaging, printing, CAD/CAM solutions, and teledentistry to support dental practices amid COVID-19. Key presentations include risk mitigation technologies and office design insights. Additionally, Henry Schein will feature interactive discussions with industry leaders on diagnostic testing and teledentistry. This event aims to provide dental professionals with innovative solutions to enhance practice efficiency and patient care.
Henry Schein, a leading provider of health care solutions, will present at three investor conferences in December 2020. The events include the Piper Sandler 32nd Annual Healthcare Conference on December 1 at 1:00 p.m. ET, Evercore ISI 3rd Annual HealthCONx Virtual Conference on December 2 at 10:30 a.m. ET, and Nasdaq 43rd Virtual Investor Conference on December 4 at 11:30 a.m. ET. These presentations can be accessed via live webcast on the company's website, with replays available afterward.
Henry Schein reported record financial results for Q3 2020, with net sales reaching $2.8 billion, a 13.2% increase from Q3 2019. GAAP net income from continuing operations was $141.7 million or $0.99 per diluted share, reflecting an increase from the previous year. Non-GAAP net income grew to $147.0 million, or $1.03 per diluted share. Strong sales growth was driven by PPE and COVID-19-related products. However, the company anticipates sales growth to moderate going forward. There remains uncertainty due to the pandemic, prompting the company to withhold future financial guidance.
Henry Schein announced an exclusive distribution agreement with Carrizo Dental to distribute Henry Schein-brand products in Argentina. This partnership enhances access to a variety of dental supplies for local practitioners, who previously had to import products from other markets. The agreement aims to streamline the purchasing process and improve clinical outcomes with local support and product training available. This collaboration reflects Henry Schein’s commitment to advancing local oral health care in Argentina.
FAQ
What is the current stock price of Henry Schein (HSIC)?
What is the market cap of Henry Schein (HSIC)?
What does Henry Schein Inc. do?
How many team members does Henry Schein employ?
What segments does Henry Schein operate in?
How many products does Henry Schein offer?
Who are Henry Schein's primary customers?
What kind of technology solutions does Henry Schein provide?
Is Henry Schein a Fortune 500 company?
What stock market indexes is Henry Schein a part of?
How many customers does Henry Schein serve?
Does Henry Schein have any recent achievements?
